KUKJEON PHARMACEUTICAL Balance Sheet Health
Financial Health criteria checks 3/6
KUKJEON PHARMACEUTICAL has a total shareholder equity of ₩97.5B and total debt of ₩78.2B, which brings its debt-to-equity ratio to 80.3%. Its total assets and total liabilities are ₩225.1B and ₩127.6B respectively. KUKJEON PHARMACEUTICAL's EBIT is ₩6.5B making its interest coverage ratio 1.6. It has cash and short-term investments of ₩64.8B.
Key information
80.3%
Debt to equity ratio
₩78.21b
Debt
Interest coverage ratio | 1.6x |
Cash | ₩64.83b |
Equity | ₩97.46b |
Total liabilities | ₩127.65b |
Total assets | ₩225.10b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: A307750's short term assets (₩124.0B) exceed its short term liabilities (₩99.8B).
Long Term Liabilities: A307750's short term assets (₩124.0B) exceed its long term liabilities (₩27.8B).
Debt to Equity History and Analysis
Debt Level: A307750's net debt to equity ratio (13.7%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if A307750's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: A307750's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: A307750's interest payments on its debt are not well covered by EBIT (1.6x coverage).